Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ming-Wei Ma
Toxicity and Biochemical Outcomes of Dose-Intensified Post-Operative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Related publications
Dose-Intensified Hypofractionated Stereotactic Body Radiation Therapy for Painful Spinal Metastases: Results of a Phase 2 Study
Cancer
Cancer Research
Oncology
Outcomes and Toxicity From a Prospective Study of Moderate Hypofractionated Radiation Therapy for Prostate Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
(P044) Toxicity of Post-Operative Intensity Modulated Radiation Therapy in Patients With Cervical Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Toxicity and Patient-Reported Outcomes of a Phase 2 Randomized Trial of Prostate and Pelvic Lymph Node Versus Prostate Only Radiotherapy in Advanced Localised Prostate Cancer (PIVOTAL)
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Improving Bone Health in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: Results of a Randomized Phase 2 Trial
Cancer
Cancer Research
Oncology
Prostate Cancer and Hypofractionation: Reflections on Recent Randomised Phase III Clinical Trial Results
Translational Andrology and Urology
Reproductive Medicine
Urology
Tri-Modality Therapy With I-125 Brachytherapy, External Beam Radiation Therapy, and Short- Or Long-Term Hormone Therapy for High-Risk Localized Prostate Cancer (TRIP): Study Protocol for a Phase III, Multicenter, Randomized, Controlled Trial
BMC Cancer
Cancer Research
Oncology
Genetics
Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial
BJU International
Urology
Prospective Phase II Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging